JP2019518036A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518036A5
JP2019518036A5 JP2018565285A JP2018565285A JP2019518036A5 JP 2019518036 A5 JP2019518036 A5 JP 2019518036A5 JP 2018565285 A JP2018565285 A JP 2018565285A JP 2018565285 A JP2018565285 A JP 2018565285A JP 2019518036 A5 JP2019518036 A5 JP 2019518036A5
Authority
JP
Japan
Prior art keywords
hydroxy
dihydropyrimidine
benzenesulfonyl
butyl
methylpyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018565285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518036A (ja
JP6993357B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/037405 external-priority patent/WO2017218633A1/en
Publication of JP2019518036A publication Critical patent/JP2019518036A/ja
Publication of JP2019518036A5 publication Critical patent/JP2019518036A5/ja
Application granted granted Critical
Publication of JP6993357B2 publication Critical patent/JP6993357B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018565285A 2016-06-14 2017-06-14 Apjアゴニストとしての6-ヒドロキシ-5-(フェニル/ヘテロアリールスルホニル)ピリミジン-4(1h)-オン Active JP6993357B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662349692P 2016-06-14 2016-06-14
US62/349,692 2016-06-14
PCT/US2017/037405 WO2017218633A1 (en) 2016-06-14 2017-06-14 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists

Publications (3)

Publication Number Publication Date
JP2019518036A JP2019518036A (ja) 2019-06-27
JP2019518036A5 true JP2019518036A5 (enExample) 2020-11-12
JP6993357B2 JP6993357B2 (ja) 2022-01-13

Family

ID=59153323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018565285A Active JP6993357B2 (ja) 2016-06-14 2017-06-14 Apjアゴニストとしての6-ヒドロキシ-5-(フェニル/ヘテロアリールスルホニル)ピリミジン-4(1h)-オン

Country Status (7)

Country Link
US (1) US10508104B2 (enExample)
EP (1) EP3468956B1 (enExample)
JP (1) JP6993357B2 (enExample)
KR (1) KR102384668B1 (enExample)
CN (1) CN109311821B (enExample)
ES (1) ES2863903T3 (enExample)
WO (1) WO2017218633A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY189453A (en) 2015-06-03 2022-02-14 Bristol Myers Squibb Co 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
CA3001974A1 (en) 2015-10-14 2017-04-20 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as apj agonists
WO2017096130A1 (en) 2015-12-04 2017-06-08 Bristol-Myers Squibb Company Apelin receptor agonists and methods of use
TW201725203A (zh) 2015-12-16 2017-07-16 必治妥美雅史谷比公司 作為apj受體促效劑之雜芳基羥基嘧啶酮
MA43761A (fr) 2016-03-24 2021-05-05 Bristol Myers Squibb Co 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj
WO2017192485A1 (en) 2016-05-03 2017-11-09 Amgen Inc. Heterocyclic triazole compounds as agonists of the apj receptor
KR102521955B1 (ko) 2016-06-14 2023-04-13 브리스톨-마이어스 스큅 컴퍼니 Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
EP3526198B1 (en) 2016-10-14 2020-08-12 Bristol-Myers Squibb Company 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists
MA46827A (fr) 2016-11-16 2019-09-25 Amgen Inc Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
EP3541792B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
WO2018097945A1 (en) 2016-11-16 2018-05-31 Amgen Inc. Heteroaryl-substituted triazoles as apj receptor agonists
WO2018093580A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
US11191762B2 (en) 2016-11-16 2021-12-07 Amgen Inc. Alkyl substituted triazole compounds as agonists of the APJ Receptor
WO2019089335A1 (en) 2017-11-03 2019-05-09 Amgen Inc. Fused triazole agonists of the apj receptor
US20210009711A1 (en) * 2018-03-14 2021-01-14 Elstar Therapeutics, Inc. Multifunctional molecules and uses thereof
WO2019213006A1 (en) 2018-05-01 2019-11-07 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014014A2 (en) * 1993-11-19 1995-05-26 Parke, Davis & Company Pyrone derivatives as protease inhibitors and antiviral agents
US5691335A (en) * 1994-07-29 1997-11-25 Suntory Limited Imidazolidine derivative and use thereof
JP3537231B2 (ja) * 1995-07-24 2004-06-14 第一サントリーファーマ株式会社 ヒダントイン誘導体およびその用途
US10570128B2 (en) * 2014-05-28 2020-02-25 Sanford Burnham Prebys Medical Discovery Institute Agonists of the apelin receptor and methods of use thereof
MY189453A (en) 2015-06-03 2022-02-14 Bristol Myers Squibb Co 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
CA3001974A1 (en) 2015-10-14 2017-04-20 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as apj agonists
WO2017096130A1 (en) 2015-12-04 2017-06-08 Bristol-Myers Squibb Company Apelin receptor agonists and methods of use
TW201725203A (zh) 2015-12-16 2017-07-16 必治妥美雅史谷比公司 作為apj受體促效劑之雜芳基羥基嘧啶酮
MA43761A (fr) 2016-03-24 2021-05-05 Bristol Myers Squibb Co 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj
KR102521955B1 (ko) 2016-06-14 2023-04-13 브리스톨-마이어스 스큅 컴퍼니 Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
EP3526198B1 (en) 2016-10-14 2020-08-12 Bristol-Myers Squibb Company 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists

Similar Documents

Publication Publication Date Title
JP2019518036A5 (enExample)
JP2018535999A5 (enExample)
JP2020515575A5 (enExample)
JP2019532072A5 (enExample)
JP2019509319A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2019518041A5 (enExample)
JP2019537571A5 (enExample)
JP2018530591A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2007523208A5 (enExample)
JP2010533158A5 (enExample)
JP2018118992A5 (enExample)
RU2016108753A (ru) Ингибиторы ферментов
JP2020506946A5 (enExample)
HRP20191327T1 (hr) 4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
JP2007530690A5 (enExample)
JP2014511869A5 (enExample)
RU2006133909A (ru) Производные азабицикло {3. 1. 0}гексана, применимые в качестве модуляторов допаминовых рецепторов d3
JP2017524026A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2017500364A5 (enExample)
JP2019537603A5 (enExample)
JP2015528022A5 (enExample)
JP2010508338A5 (enExample)